News >

Chemoradiation and Radiation Produced Similar Outcomes in Extremity Soft Tissue Sarcoma

Jason Harris
Published: Thursday, May 18, 2017

sarcoma
Researchers at Istanbul University Institute of Oncology have concluded that patients with high-risk extremity soft tissue sarcoma have similar 3-year outcomes whether they are assigned to neoadjuvant sequential chemoradiotherapy or radiation alone. The findings were published in Contemporary Oncology.

“At the end of the day, radiation therapy in the setting of limb-sparing resection demonstrates good local control with or without chemotherapy,” she said. “And each patient, as an individual, needs to be assessed as to the relevance of chemotherapy for their cancer as it is highly dependent on staging and histologic subtypes."
Kılıç L, Ekene M, Karabulut S, Ağaoğlu F, Darendeliler E. Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience. Contemp Oncol. 2017;21(1):60-65. doi:10.5114/wo.2017.66658.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x